{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:25:44Z","timestamp":1760984744702},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T00:00:00Z","timestamp":1366761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00535-013-0795-0","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T21:12:04Z","timestamp":1367356324000},"page":"332-342","source":"Crossref","is-referenced-by-count":19,"title":["Genetic polymorphisms of OCT-1 confer susceptibility to severe progression of primary biliary cirrhosis in Japanese patients"],"prefix":"10.1007","volume":"49","author":[{"name":"PBC Study Group of NHOSLJ","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Ohishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Nakamuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ohki","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsumasa","family":"Komori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yatsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyoshi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyuki","family":"Kohjima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunitaka","family":"Fukuizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Shirabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinobu","family":"Taketomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,24]]},"reference":[{"key":"795_CR1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353:1261\u201373.","journal-title":"N Engl J Med"},{"key":"795_CR2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","volume":"45","author":"M Nakamura","year":"2007","unstructured":"Nakamura M, Kondo H, Mori T, et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology. 2007;45:118\u201327.","journal-title":"Hepatology"},{"key":"795_CR3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1034\/j.1600-0528.2002.017402.x","volume":"174","author":"ME Gershwin","year":"2000","unstructured":"Gershwin ME, Ansari AA, Mackay IR, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev. 2000;174:210\u201325.","journal-title":"Immunol Rev"},{"key":"795_CR4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0168-8278(00)00040-4","volume":"34","author":"P Invernizzi","year":"2001","unstructured":"Invernizzi P, Podda M, Battezzati PM, et al. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol. 2001;34:366\u201372.","journal-title":"J Hepatol"},{"key":"795_CR5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2004.11.016","volume":"42","author":"M Nakamura","year":"2005","unstructured":"Nakamura M, Shimizu-Yoshida Y, Takii Y, et al. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol. 2005;42:386\u201392.","journal-title":"J Hepatol"},{"key":"795_CR6","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.21172","volume":"43","author":"J Wesierska-Gadek","year":"2006","unstructured":"Wesierska-Gadek J, Penner E, Battezzati PM, et al. Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology. 2006;43:1135\u201344.","journal-title":"Hepatology"},{"key":"795_CR7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1568-9972(03)00013-2","volume":"2","author":"HJ Worman","year":"2003","unstructured":"Worman HJ, Courvalin J-C. Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev. 2003;2:211\u20137.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"795_CR8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jhep.2009.11.027","volume":"52","author":"R Poupon","year":"2010","unstructured":"Poupon R. Primary biliary cirrhosis: a 2010 update. J Hepatol. 2010;52(5):745\u201358.","journal-title":"J Hepatol"},{"issue":"2","key":"795_CR9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","volume":"128","author":"C Corpechot","year":"2005","unstructured":"Corpechot C, Carrat F, Bahr A, et al. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology. 2005;128(2):297\u2013303.","journal-title":"Gastroenterology"},{"key":"795_CR10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.gene.6364248","volume":"6","author":"C Selmi","year":"2005","unstructured":"Selmi C, Invernizzi P, Zuin M, et al. Genes and (auto)immunity in primary biliary cirrhosis. Genes Immun. 2005;6:543\u201356.","journal-title":"Genes Immun"},{"issue":"7","key":"795_CR11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.gene.6364248","volume":"6","author":"C Selmi","year":"2005","unstructured":"Selmi C, Invernizzi P, Zuin M, et al. Genes and (auto) immunity in primary biliary cirrhosis. Genes Immun. 2005;6(7):543\u201356.","journal-title":"Genes Immun"},{"issue":"4","key":"795_CR12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/gut.36.4.615","volume":"36","author":"AM Brind","year":"1995","unstructured":"Brind AM, Bray GP, Portmann BC, et al. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut. 1995;36(4):615\u20137.","journal-title":"Gut"},{"issue":"10","key":"795_CR13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00535-011-0417-7","volume":"46","author":"Y Aiba","year":"2011","unstructured":"Aiba Y, Nakamura M, Joshita S, et al. Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients. J Gastroenterol. 2011;46(10):1203\u201312.","journal-title":"J Gastroenterol"},{"issue":"5","key":"795_CR14","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0168-8278(99)80135-4","volume":"30","author":"A Tanaka","year":"1999","unstructured":"Tanaka A, Quaranta S, Mattalia A, et al. The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosis. J Hepatol. 1999;30(5):826\u20139.","journal-title":"J Hepatol"},{"issue":"10","key":"795_CR15","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1046\/j.1440-1746.2003.03160.x","volume":"18","author":"C Selmi","year":"2003","unstructured":"Selmi C, Zuin M, Biondi ML, et al. Genetic variants of endothelial nitric oxide synthase in patients with primary biliary cirrhosis: association with disease severity. J Gastroenterol Hepatol. 2003;18(10):1150\u20135.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"795_CR16","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2008.07.027","volume":"49","author":"R Poupon","year":"2008","unstructured":"Poupon R, Ping C, Chr\u00e9tien Y, et al. Genetic factors of susceptibility and of severity in primary biliary cirrhosis. J Hepatol. 2008;49(6):1038\u201345.","journal-title":"J Hepatol"},{"issue":"2","key":"795_CR17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.23041","volume":"50","author":"B Zhong","year":"2009","unstructured":"Zhong B, Strnad P, Selmi C, et al. Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity. Hepatology. 2009;50(2):546\u201354.","journal-title":"Hepatology"},{"issue":"1","key":"795_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20516","volume":"41","author":"Y Kimura","year":"2005","unstructured":"Kimura Y, Selmi C, Leung PS, et al. Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis. Hepatology. 2005;41(1):55\u201363.","journal-title":"Hepatology"},{"issue":"4","key":"795_CR19","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1053\/j.gastro.2008.06.077","volume":"135","author":"BD Juran","year":"2008","unstructured":"Juran BD, Atkinson EJ, Schlicht EM, et al. Primary biliary cirrhosis is associated with a genetic variant in the 3\u2032 flanking region of the CTLA4 gene. Gastroenterology. 2008;135(4):1200\u20136.","journal-title":"Gastroenterology"},{"issue":"3","key":"795_CR20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/gut.48.3.397","volume":"48","author":"P Donaldson","year":"2001","unstructured":"Donaldson P, Agarwal K, Craggs A, et al. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut. 2001;48(3):397\u2013402.","journal-title":"Gut"},{"issue":"5","key":"795_CR21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s00535-010-0351-0","volume":"46","author":"T Inamine","year":"2011","unstructured":"Inamine T, Nakamura M, Kawauchi A, et al. A polymorphism in the integrin \u03b1V subunit gene affects the progression of primary biliary cirrhosis in Japanese patients. J Gastroenterol. 2011;46(5):676\u201386.","journal-title":"J Gastroenterol"},{"issue":"4","key":"795_CR22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.789","volume":"43","author":"GF Mells","year":"2011","unstructured":"Mells GF, Floyd JA, Morley KI, et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet. 2011;43(4):329\u201332.","journal-title":"Nat Genet"},{"key":"795_CR23","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","volume":"360","author":"GM Hirschfield","year":"2009","unstructured":"Hirschfield GM, Liu X, Xu C, et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med. 2009;360:2544\u201355.","journal-title":"N Engl J Med"},{"issue":"8","key":"795_CR24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ng.631","volume":"42","author":"GM Hirschfield","year":"2010","unstructured":"Hirschfield GM, Liu X, Han Y, et al. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet. 2010;42(8):655\u20137.","journal-title":"Nat Genet"},{"issue":"1","key":"795_CR25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1399-0039.2011.01684.x","volume":"78","author":"A Tanaka","year":"2011","unstructured":"Tanaka A, Invernizzi P, Ohira H, et al. Replicated association of 17q12-21 with susceptibility of primary biliary cirrhosis in a Japanese cohort. Tissue Antigens. 2011;78(1):65\u20138.","journal-title":"Tissue Antigens"},{"issue":"8","key":"795_CR26","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ng.627","volume":"42","author":"X Liu","year":"2010","unstructured":"Liu X, Invernizzi P, Lu Y, et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet. 2010;42(8):658\u201360.","journal-title":"Nat Genet"},{"key":"795_CR27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajhg.2012.08.010","volume":"91","author":"M Nakamura","year":"2012","unstructured":"Nakamura M, Nishida N, Kawashima M, et al. Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet. 2012;91:721\u20138.","journal-title":"Am J Hum Genet"},{"key":"795_CR28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00008571-200402000-00003","volume":"14","author":"C Pauli-Magnus","year":"2004","unstructured":"Pauli-Magnus C, Lang T, Meier Y, et al. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics. 2004;14:91\u2013102.","journal-title":"Pharmacogenetics"},{"key":"795_CR29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.95.1.282","volume":"95","author":"JML Vree de","year":"1998","unstructured":"de Vree JML, Jacquemin E, Sturm E, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA. 1998;95:282\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"795_CR30","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","volume":"120","author":"E Jacquemin","year":"2001","unstructured":"Jacquemin E, de Vree JML, Cresteil D, et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology. 2001;120:1448\u201358.","journal-title":"Gastroenterology"},{"issue":"3","key":"795_CR31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/hep.22382","volume":"48","author":"Y Ohishi","year":"2008","unstructured":"Ohishi Y, Nakamura M, Iio N, et al. Single-nucleotide polymorphism analysis of the multidrug resistance protein 3 gene for the detection of clinical progression in Japanese patients with primary biliary cirrhosis. Hepatology. 2008;48(3):853\u201362.","journal-title":"Hepatology"},{"key":"795_CR32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","volume":"75","author":"JJ Smit","year":"1993","unstructured":"Smit JJ, Schinkel AH, Oude Elferink RP, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell. 1993;75:451\u201362.","journal-title":"Cell"},{"key":"795_CR33","doi-asserted-by":"crossref","unstructured":"Oude Elferink RP, Ottenhoff R, van Wijland M, et al. Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. J Clin Invest. 1995;95:31\u20138.","DOI":"10.1172\/JCI117658"},{"key":"795_CR34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0006-3495(93)81047-6","volume":"65","author":"S Ali","year":"1993","unstructured":"Ali S, Zakim D. The effects of bilirubin on the thermal properties of phosphatidylcholine bilayers. Biophys J. 1993;65:101\u20135.","journal-title":"Biophys J"},{"key":"795_CR35","doi-asserted-by":"crossref","unstructured":"Oude Elferink RP, Paulusma CC. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Eur J Physiol. 2007;453:601\u201310.","DOI":"10.1007\/s00424-006-0062-9"},{"issue":"5","key":"795_CR36","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/153537020623100503","volume":"231","author":"V Michel","year":"2006","unstructured":"Michel V, Yuan Z, Ramsubir S, et al. Choline transport for phospholipid synthesis. Exp Biol Med (Maywood). 2006;231(5):490\u2013504.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"11","key":"795_CR37","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0022-2275(20)31978-7","volume":"41","author":"CJ Sinclair","year":"2000","unstructured":"Sinclair CJ, Chi KD, Subramanian V, et al. Functional expression of a high affinity mammalian hepatic choline\/organic cation transporter. J Lipid Res. 2000;41(11):1841\u20138.","journal-title":"J Lipid Res"},{"issue":"7","key":"795_CR38","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1096\/fasebj.5.7.2010061","volume":"5","author":"SH Zeisel","year":"1991","unstructured":"Zeisel SH, Da Costa KA, Franklin PD, et al. Choline, an essential nutrient for humans. FASEB J. 1991;5(7):2093\u20138.","journal-title":"FASEB J"},{"issue":"4","key":"795_CR39","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.23103","volume":"50","author":"AT Nies","year":"2009","unstructured":"Nies AT, Koepsell H, Winter S, et al. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology. 2009;50(4):1227\u201340.","journal-title":"Hepatology"},{"issue":"4","key":"795_CR40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/tpj.2009.15","volume":"9","author":"ML Becker","year":"2009","unstructured":"Becker ML, Visser LE, van Schaik RH, et al. Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus. Pharmacogenomics J. 2009;9(4):242\u20137.","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"795_CR41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology. 2009;50(1):291\u2013308.","journal-title":"Hepatology"},{"key":"795_CR42","first-page":"1257","volume":"60","author":"PJ Scheuer","year":"1967","unstructured":"Scheuer PJ. Primary biliary cirrhosis. Proc R Soc Med. 1967;60:1257\u201360.","journal-title":"Proc R Soc Med"},{"key":"795_CR43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(00)81370-7","volume":"87","author":"A Helvoort van","year":"1996","unstructured":"van Helvoort A, Smith AJ, Sprong H, et al. MDR1 P-glycoprotein is a lipid translocase if broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell. 1996;87:507\u201317.","journal-title":"Cell"},{"issue":"3","key":"795_CR44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11095-008-9770-5","volume":"26","author":"HE Jin","year":"2009","unstructured":"Jin HE, Hong SS, Choi MK, et al. Reduced antidiabetic effect of metformin and down-regulation of hepatic Oct1 in rats with ethynyl estradiol-induced cholestasis. Pharm Res. 2009;26(3):549\u201359.","journal-title":"Pharm Res"},{"issue":"5","key":"795_CR45","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/hep.20176","volume":"39","author":"GU Denk","year":"2004","unstructured":"Denk GU, Soroka CJ, Mennone A, et al. Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis. Hepatology. 2004;39(5):1382\u20139.","journal-title":"Hepatology"},{"issue":"1","key":"795_CR46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10048-010-0254-5","volume":"12","author":"ML Becker","year":"2011","unstructured":"Becker ML, Visser LE, van Schaik RH, et al. OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users. Neurogenetics. 2011;12(1):79\u201382.","journal-title":"Neurogenetics."},{"key":"795_CR47","doi-asserted-by":"crossref","unstructured":"Klaassen CD, Aleksunes LM. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev. 2010;62(1):1\u201396.","DOI":"10.1124\/pr.109.002014"},{"issue":"1","key":"795_CR48","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.103.053298","volume":"308","author":"JW Jonker","year":"2004","unstructured":"Jonker JW, Schinkel AH. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharmacol Exp Ther. 2004;308(1):2\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"795_CR49","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bbrc.2003.11.175","volume":"313","author":"T Sakata","year":"2004","unstructured":"Sakata T, Anzai N, Shin HJ, et al. Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions. Biochem Biophys Res Commun. 2004;313(3):789\u201393.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"795_CR50","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1073\/pnas.0730858100","volume":"100","author":"Y Shu","year":"2003","unstructured":"Shu Y, Leabman MK, Feng B, et al. Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci USA. 2003;100(10):5902\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"795_CR51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1124\/jpet.110.170159","volume":"335","author":"L Chen","year":"2010","unstructured":"Chen L, Takizawa M, Chen E, et al. Genetic polymorphisms in organic cation transporter 1 (OCT1) in Chinese and Japanese populations exhibit altered function. J Pharmacol Exp Ther. 2010;335(1):42\u201350.","journal-title":"J Pharmacol Exp Ther"},{"key":"795_CR52","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1872-034X.2010.00631.x","volume":"40","author":"M Nakamura","year":"2010","unstructured":"Nakamura M, Yasunami M, Kondo H, et al. Analysis of HLA-DRB1 polymorphisms in Japanese patients with primary biliary cirrhosis (PBC): the HLA-DRB1 polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC. Hepatol Res. 2010;40:494\u2013504.","journal-title":"Hepatol Res"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-013-0795-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-013-0795-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-013-0795-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T15:27:59Z","timestamp":1644938879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-013-0795-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,24]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["795"],"URL":"https:\/\/doi.org\/10.1007\/s00535-013-0795-0","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"type":"print","value":"0944-1174"},{"type":"electronic","value":"1435-5922"}],"subject":[],"published":{"date-parts":[[2013,4,24]]}}}